NCT03485339View on ClinicalTrials.gov

Substance Misuse To Psychosis for Ketamine (SToP-K)

CompletedOBSERVATIONAL
Enrollment

162

Participants

Timeline

Start Date

June 12, 2018

Primary Completion Date

March 1, 2020

Study Completion Date

April 1, 2020

Conditions
Ketamine AbusePsychotic DisordersSubstance Use DisordersSchizophreniaGenetic Predisposition
Interventions
DIAGNOSTIC_TEST

genome testing

blood sampling via venipuncture

Trial Locations (2)

000000

Queen Mary Hospital, Hong Kong

00000

Western Psychiatric Centre, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER

NCT03485339 - Substance Misuse To Psychosis for Ketamine (SToP-K) | Biotech Hunter | Biotech Hunter